Difficulty: Medium
Average Score: 94%
Practice
Children with high-risk neuroblastoma have poor survival. Current treatment consists of all the following EXCEPT
Correct answer
D
Rationale
In the treatment of high-risk neuroblastoma in children, current protocols involve a multimodal approach that includes surgery, intensive chemotherapy, and radiation therapy. Allogeneic bone marrow transplantation is not a standard part of the treatment regimen for high-risk neuroblastoma in children.
The correct answer, D, is not a part of the standard treatment because allogeneic bone marrow transplantation has not demonstrated significant efficacy in improving outcomes for children with high-risk neuroblastoma. While bone marrow transplantation may be considered in certain cases or in research settings, it is not a routine part of the established treatment guidelines for this condition.
Surgery is often used to remove the primary tumor and any metastatic sites, while intensive chemotherapy and radiation therapy are aimed at eradicating remaining cancer cells. These modalities have been shown to improve survival rates in children with high-risk neuroblastoma.
In an educational context, understanding the rationale behind each treatment modality is crucial for healthcare providers caring for pediatric oncology patients. It is important to be aware of the current evidence-based practices to provide the best possible care and outcomes for children with high-risk neuroblastoma. By knowing which treatments are standard and which are not, healthcare professionals can make informed decisions and advocate for the most effective therapies for their young patients.
The correct answer, D, is not a part of the standard treatment because allogeneic bone marrow transplantation has not demonstrated significant efficacy in improving outcomes for children with high-risk neuroblastoma. While bone marrow transplantation may be considered in certain cases or in research settings, it is not a routine part of the established treatment guidelines for this condition.
Surgery is often used to remove the primary tumor and any metastatic sites, while intensive chemotherapy and radiation therapy are aimed at eradicating remaining cancer cells. These modalities have been shown to improve survival rates in children with high-risk neuroblastoma.
In an educational context, understanding the rationale behind each treatment modality is crucial for healthcare providers caring for pediatric oncology patients. It is important to be aware of the current evidence-based practices to provide the best possible care and outcomes for children with high-risk neuroblastoma. By knowing which treatments are standard and which are not, healthcare professionals can make informed decisions and advocate for the most effective therapies for their young patients.